Company / Current Assets
Marker Therapeutics, Inc. Current Assets History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$46.0M
FY2021
5-year range
$45.5M / $62.0M
FY2018-FY2021
Trend
+1.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $62M to $46M over the past 3 years.
Based on SEC 10-K filings.
$46M in FY2021.
Declined from $62M to $46M over the past 3 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -9.5%, indicating a declining trend.
- In FY2021, current assets increased 1.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $46.0M | +1.1% |
| FY2019 | $45.5M | -26.6% |
| FY2018 | $62.0M | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026